LUNG
Pulmonx Corporation
$1.84
+$0.15(+8.88%)
48
Overall
60
Value
36
Tech
--
Quality
Market Cap
$68.86M
Volume
585.83K
52W Range
$1.47 - $9.37
Target Price
$6.38
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $32.7M | $48.4M | $53.7M | $68.7M | $83.8M | ||
| Total Revenue | $32.7M | $48.4M | $53.7M | $68.7M | $83.8M | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | $11.5M | $12.8M | $13.8M | $17.9M | $21.8M | ||
| GROSS PROFIT | |||||||
| Gross Profit | $21.2M | $35.6M | $39.9M | $50.8M | $62.0M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $53.5M | $82.9M | $98.5M | $112.7M | $119.7M | ||
| Research & Development | $7.5M | $13.1M | $15.4M | $18.1M | $17.6M | ||
| Research Expense | $7.5M | $13.1M | $15.4M | $18.1M | $17.6M | ||
| Selling, General & Administrative | $46.1M | $69.9M | $83.1M | $94.6M | $102.1M | ||
| Selling & Marketing Expenses | $1.5M | $5.1M | $6.1M | $4.8M | $7.9M | ||
| General & Administrative Expenses | $46.1M | $69.9M | $83.1M | $94.6M | $102.1M | ||
| Promotion & Advertising | $1.5M | $5.1M | $6.1M | $4.8M | $7.9M | ||
| Salaries & Wages | $300.0K | -- | -- | $22.1M | $23.0M | ||
| Depreciation & Amortization | $300.0K | $700.0K | $1.4M | $1.4M | $1.1M | ||
| Depreciation & Amortization | $300.0K | $700.0K | $1.4M | $1.4M | $1.1M | ||
| Amortization | $3.3M | $2.4M | $2.4M | $2.4M | $2.4M | ||
| Other Operating Expenses | $-7.3M | $-68.0K | $-200.0K | $-38.0K | $-40.0K | ||
| OPERATING INCOME | |||||||
| Operating income | $-32.3M | $-47.3M | $-58.6M | $-61.9M | $-57.7M | ||
| EBITDA | $-28.4M | $-46.6M | $-56.0M | $-56.0M | $-49.0M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $3.2M | $829.0K | $1.1M | $3.2M | $3.5M | ||
| Intinc | $213.0K | $400.0K | $1.5M | $5.6M | $5.1M | ||
| Net Non-Operating Interest Income/Expense | $-3.0M | $-429.0K | $463.0K | $5.6M | $5.1M | ||
| Other Income/Expense | $-3.3M | $585.0K | $-396.0K | $673.0K | $-256.0K | ||
| Other Special Charges | $3.3M | $-585.0K | $-396.0K | $-673.0K | $256.0K | ||
| SPECIAL ITEMS | |||||||
| Special Income Charges | -- | -- | -- | -- | $-1.7M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | $1.7M | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-28.8M | $-47.5M | $-57.5M | $-60.3M | $-52.4M | ||
| Pre-Tax Income | $-32.0M | $-48.3M | $-58.6M | $-60.3M | $-55.9M | ||
| INCOME TAX | |||||||
| Tax Provision | $213.0K | $343.0K | $353.0K | $571.0K | $500.0K | ||
| NET INCOME | |||||||
| Net Income | $-32.2M | $-48.7M | $-58.9M | $-60.8M | $-56.4M | ||
| Net Income (Continuing Operations) | $-32.2M | $-48.7M | $-58.9M | $-60.8M | $-56.4M | ||
| Net Income (Discontinued Operations) | $-32.2M | $-48.7M | $-58.9M | $-60.8M | $-56.4M | ||
| Net Income (Common Stockholders) | $-32.2M | $-48.7M | $-58.9M | $-60.8M | $-56.4M | ||
| TOTALS | |||||||
| Total Expenses | $65.1M | $95.7M | $112.3M | $130.6M | $141.5M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $10.2M | $36.1M | $37.1M | $38.0M | $39.1M | ||
| Average Shares Outstanding (Diluted) | -- | $36.1M | $37.1M | $38.0M | $39.1M | ||
| Shares Outstanding | $35.7M | $37.0M | $37.6M | $38.5M | $39.8M | ||
| Basic EPS | $-3.16 | $-1.35 | $-1.59 | $-1.6 | $-1.44 | ||
| Basic EPS (Continuing Operations) | $-3.16 | $-1.35 | $-1.59 | $-1.6 | $-1.44 | ||
| Diluted EPS | $-3.16 | $-1.35 | $-1.59 | $-1.6 | $-1.44 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.35 | $-1.59 | $-1.6 | $-1.44 | ||
| OTHER METRICS | |||||||
| Other Gand A | $46.1M | $69.9M | $83.1M | $94.6M | $102.1M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LUNG | $1.84 | +8.9% | 585.83K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |